Literature DB >> 8298816

Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT.

R A Borman1, D E Burleigh.   

Abstract

5-Hydroxytryptamine increases transmucosal short-circuit current across human isolated small intestinal mucosa. The competitive 5-HT4 antagonist, DAU 6285 evoked a concentration-dependent, dextral and parallel shift of the concentration-response curve to 5-HT, with no alteration of the maximum response. Schild analysis of this antagonism produced a Schild regression with a slope of 1.00 and an apparent pA2 estimate of 6.17. It appears that a 5-HT4 receptor may mediate the short-circuit current response of human small intestinal mucosa to 5-HT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298816      PMCID: PMC2175779          DOI: 10.1111/j.1476-5381.1993.tb13901.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

Review 1.  The 5-HT4 receptor: a place in the sun.

Authors:  J Bockaert; J R Fozard; A Dumuis; D E Clarke
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

2.  DAU 6285: a novel antagonist at the putative 5-HT4 receptor.

Authors:  A Schiavone; E Giraldo; L Giudici; M Turconi; A Sagrada
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

3.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

4.  Loperamide but not morphine has anti-secretory effects in human colon, in vitro.

Authors:  D E Burleigh
Journal:  Eur J Pharmacol       Date:  1991-09-17       Impact factor: 4.432

5.  Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.

Authors:  M V Waikar; S S Hegde; A P Ford; D E Clarke
Journal:  J Pharmacol Exp Ther       Date:  1993-02       Impact factor: 4.030

6.  Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa.

Authors:  C M Scott; K T Bunce; C F Spraggs
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  Investigation of the 5-hydroxytryptamine receptor mechanism mediating the short-circuit current response in rat colon.

Authors:  K T Bunce; C J Elswood; M T Ball
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

  7 in total
  17 in total

1.  An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle.

Authors:  N H Prins; N P Shankley; N J Welsh; M R Briejer; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 2.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 3.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

4.  Serotonin via 5-HT1B and 5-HT2B receptors stimulates anion secretion in the rat epididymal epithelium.

Authors:  G P Leung; S L Dun; N J Dun; P Y Wong
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

5.  Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266.

Authors:  G J Sanger; M Yoshida; M Yahyah; K Kitazumi
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

6.  Functional evidence for a 5-HT2B receptor mediating contraction of longitudinal muscle in human small intestine.

Authors:  R A Borman; D E Burleigh
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum.

Authors:  P G McLean; I M Coupar; P Molenaar
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

8.  Prokinetic effects of LD02GIFRO on functional gastrointestinal disorder in rats.

Authors:  Myung-Joo Choi; Hong-Mei Zheng; Hee Dong Park; Hee Kyung Jeong; Soon-Sun Hong; Jae Min Kim; Don Haeng Lee
Journal:  Exp Ther Med       Date:  2017-03-06       Impact factor: 2.447

9.  Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle.

Authors:  F S Tam; K Hillier; K T Bunce; C Grossman
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 10.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.